Extracorporeal membrane oxygenation (ECMO) can be used for the treatment of acute respiratory failure. Based on recent experience in establishing such a method of treatment, this paper reviews those aspects of ECMO that need careful consideration before it can be undertaken. Methods of patient selection for ECMO and the Physiological changes associated with it are also discussed.
die either from acute hypoxia, or suffer irreversible pulmonary damage produced by conventional therapy.
At The London Hospital (where membrane oxygenators are not used for cardiac surgery) we have recently been engaged in setting up the facility for this form of therapy for acute respiratory failure. We consider the animal laboratory essential for the adapt ion and modification of existing facilities. We have used both sheep and dogs to :
1. Test a variety of pumps, membrane oxygenators and bypass circuits, and to select equipment which in our hands is the most suitable. 2. Familiarize cardiac surgery pump technicians with this equipment, which in many ways is different from that to which they are accustomed. 3. Undertake a series of prolonged perfusions (over 24 hours) on a series of sheep in order to gain experience with the management of prolonged perfusions. We have found these laboratory perfusions to be unexpectedly difficult to perform, and to be beset with numerous practical problems which we were unable to forsee. They have convinced us that the casual implementation of prolonged ECMO, using techniques and concepts taken unmodified from the cardiac theatres, is very likely to be unsuccessful for reasons unrelated to the patient's clinical condition.
This paper reviews reported experience in areas relating to ECMO which we fOlimd required prolonged consideration before a detailed regime for clinical perfusions for the treatment of acute respiratory failure could be decided upon. Mention is made of those aspects of cardiopulmonary bypass technique which differ from that used for cardiac surgery. The vexing problem of patient selection and the expected physiological changes associated with EC\IO are also discussed.
PATIE"'T SELECTIOX
In the years 19Htl-1975, 233 cases of acute respiratory failure were treated by EC\;IO by 90 medical teams in seven different countries.
The success rate in the more recent years of 1974 and 1975 has been around 19 per cent (Gille and Bagniewski 197tl) . The success using EC\10 in the earlier years has been less (196tl-1972=12 per cent) . This reflects lack of experience with the technique and the inclusion of patients who were unsuitable for EC\10. Patient selection therefore, is important.
In intensive care units, there are occasions when despite maximal ventilator therapy, high inspired oxygen concentrations (Fi0 2 ) and use of positive end expiratory pressure (PEEP), there is an inexorable fall in arterial oxygen pressure (Pa0 2 ) and compliance, as right-to-Ieft shunting and pulmonary damage increase. The natural history however, of severe pulmonary insufficiency is unknown, and aetiological and physiological characteristics of severe pulmonary insufficiency that are associated with progressive and irreversible pulmonary damage are uncertain. Potential benefits of instituting extracorporeal oxygenation of the blood in a patient with acute respiratory failure include:
]. Reversal of the deleterious physiological effects of hypoxia on vital organs. 2. The ability to undertake vigorous pulmonary toilet, physiotherapy, and pulmonary instillation of various agents while the patient is off the ventilatorprocedures that may be otherwise precluded by severe hypoxaemia. :3. A voidance of pulmonary damage which is produced by conventional therapy in an effort to maintain reasonable blood gas tensions. Although a Pa0 2 of greater than 50 mm Hg can usually be maintained by aggressive conventional therapy, this may be a t the price of progressive pulmonary fibrosis (~ash, Blennerhasset, and Pontoppidan 1967) , pulmonary sepsis (Hubert, Finder and la Force 1972) and the high inflation pressures and positive end expiratory pressure may result in various forms of barotrauma (Baeza, \Yagner and Lowery 1975, Kumar et al. 1973) . Pulmonary fibrosis and necrosis may not be reversible once established , Zapol et al. 1972 . Extracorporeal oxygenation of the blood allows reduction of inspired oxygen concentration, reduction of maximum inspiratory pressure and of the level of positive end expiratory pressure. Set against these advantages is the significant morbidity of EC\lO. Thus determining which patients may need EC\IO and when to institute therapy is difficult. There seems little doubt that excessive delay in instituting ECl\10 prejudices against successful treatment (Gille and Bagniewski 197tl) and that application to patients borne of the feeling that ' there is nothing more to lose' is unproductive. Premature use of EC\IO may expose the patient to unnecessary risk. Almost every aetiology of acute respiratory insufficiency has been treated by EOIO (Bloom et al. 1974 , Hill et al. 1974 , Geelhoed, Corso and Joseph 1974 but the most common appear to be pneumonia (particularly viral) and shock lung and failure due to fat emboli (Gille and Bagniewski 197H) . Accepting that only patients with potentially reversible pulmonary pathology should be considered, the following guidelines to patient selection may be used.
1. Blood gas reslIlts : Hill et al. (1974) consider therapy when there is gener?Jized hypoxaemia in the presence of maximum respiratory support. That is, Fi0 2 =1'0, PEEP to 15 centimetres of water and a Pa0 2 achieved of 40-n0 mm Hg. He elaborates these criteria with temporal factors-a rapidly deteriorating course with a Pa0 2 less than 50 (with Fi0 2 =1·0) present for greater than 2 hours, or deterioration after 48 hours of optimal ventilatory therapy with a Pa0 2 less than 50 mm Hg and an Fi0 2 greater than 0·6 used for more than twelve additional hours. Others basically agree with these blood gas criteria , Lefrak et al. 1973 , Rea et al. Hl73, Geelhoed et al. 1974 .
2. Evidellce of hypoxic organ depression: :\Iyocardial or cerebral depression secondary to hypoxaemia have been used as absolute criteria for institution of EOIO (Hill et al. 1974 , Geelhoed et al. 1974 . Peirce (1972) believes that EC1\10 should be begun before hypoxic organ depression develops, as severe cerebral hypoxia may cause scattered intracerebral haemorrhage. This can become significant intracerebral bleeding with the haemorrhagic tendency that accompanies heparinization and the changes in blood parameters which occur with ECMO.
3. Use of various physiological and pathological measurements,' Experience has shown that using the criteria mentioned above may result in beginning therapy when irreversible pulmonary changes are already present. Other pulmonary measurements have therefore been made. The degree of right to left shunting present in the lungs may be used to quantitate pulmonary damage (Hill et al. 1974) . Basically the QS/QT ratio is calculated from the shunt equation at varying levels of positive end expiratory pressure and at varying inspired oxygen concentrations. A reduction in the shunt fraction with increasing positive end expiratory pressure and Fi0 2 indicates a reversible element in the shunt that is due to ventilation perfusion inequality. Monitoring of the degree of 'fixed-shunting' during ventilator therapy (Hill et al. 1974) and during ECMO therapy (McEnany et al. 1975) can be undertaken. This provides an indication of when to initiate therapy (fixed shunt 50-80%) and allows the progress of lung changes during therapy to be followed (Hill et al. 1974 , McEnany et al. 1975 . The American National Heart and Lung Institute in their protocol for extracorporeal support for respiratory insufficiency (designed for a randomized study to compare the relative efficacy of ECMO and conventional therapy in cases of severe acute respiratory failure) use a combination of both blood gases and the degree of intrapulmonary shunting to decide whether or not patients whose pulmonary function has not improved with 48 hours of standard therapy require ECMO. Such patients are eligible to undergo ECMO if both a and b below obtain (a) Pa0 2 is consistently 50 mm Hg or less for 12 hours (in addition to the elapsed 48 hours with standard therapy) when PaC0 2 is between 30-45 mm Hg while the patient is ventilated with Fi0 2 ;;;;.0· 6 and PEEP;;;;'5 cm H 2 0. (b) There is a veno-arterial shunt greater than 30 per cent of the cardiac output when measured after at least 15 minutes with Fi0 2 =1·0 and PEEP;;;;'5 cm H 2 0. Pulmonary function can also be followed by measuring compliance , Geelhoed et al. 1974 )-effective or quasistatic measurement is made by dividing tidal volume by the pressure gradient necessary to achieve it (under standardized conditions). Although obviously open to error, it is a simple non- Anaesthesia and Intensive Care, Vol. V, No. 2, May, 1977 invasive measurement that will reflect pulmonary changes. Measurements of functional residual capacity is also useful ) and calculation of pulmonary vascular resistance allows assessment of the degree of destruction of pulmonary vasculature , Bartlett et al. 1974 . There are also other more complicated formulae to assess lung damage such as the pulmonary insufficiency index (Bartlett et al. 1974) . Whatever parameters of this nature are followed, their routine use in all severe cases of respiratory insufficiency will allow experience to be obtained, and some data gathered, to relate the course and prognosis of the disease process with the measurement made. Lung biopsy has been used to assess lung damage, and open biopsy has been used in patient selection (Hill et al. 1974 , Bartlett ct al. 1974 . Problems with biopsy are bleeding if ECMO is instituted, air leaks, and the possibility that the sample taken may be unrepresentative . Pathological criteria are by no means well defined. Gross changes that ,"eem to indicate diffuse pulmonary fibrosis are diffuse cystic necrosis, diffuse pulmonary haemorrhage and nodular intrapulmonary masses (Hill et al. 1974) . Microscopic changes associated with progressive pulmonary damage include loss of pulmonary architecture and fibroblastic or collagen infiltration (Hill et al. 1974) . Microscopic changes that may be associated with reversible pulmonary pathology are interstitial oedema, alveolar infiltrates, hyaline membranes, fat emboli and non specific inflammatory cell responses (Hill et al. 1974) . Failed ECMO cases with progressive pulmonary deterioration have at autopsy revealed fibrosis, loss of alveoli, cystic degeneration and necrotizing pneumonitis (Bartlett et al. 1974) . Lung biopsy therefore, is associated with some risk, and at present the presence or absence of fibrosis seems to be the only change that may give an indication of prognosis, albeit poor (Hill et al. 1974 . Lung biopsy has been considered by some as unhelpful if disease is of short duration . Others have used calculation of pulmonary vascular resistance to indicate the probable presence of pulmo'1ary fibrosis, and have used lung biopsy to detect fibrosis more directly when the pulmonary vascular resistance equals systemic vascular resistance , Bartlett et al. 1974 . At present it would seem reasonable to avoid lung biopsy unless pulmonary disease has been protracted and other criteria are equivocal.
Finally with regard to patient selection, the experienced intensive care worker has a well developed 'gut feeling' as to which patients are progressing well or otherwise with conventional therapy.
Which patients have a favourable prognosis if Eo.10 is begun? The following appear to be of importance:
a. Duration of illness Patients with a short severe disease process leading to respiratory insufficiency (e.g. traumatic fat embolism) appear to have a better survival rate than those with a subacute protracted illness which necessitates ECMO after 12-14 days (Hill et al. 1974 , Lefrak et al. 1973 , Gille and Bagniewski 1976 . b. Presence of pulmonary fibrosis Gross or microscopic fibrosis is associated with a poor prognosis (Hill et al. 1974 , Bartlett et al. 1974 e. Existence of a contraindication to anticoagulation e.g. recent cerebrovascular accident.
£. Respiratory failure present for more than three weeks (Hill et al. 1974) .
Recent or proposed surgery may complicate the decision to institute EC\10. Such cases are post-cardiac bypass respiratory insufficiency, pulmonary embolism and multiple trauma. Although bleeding is a major problem during ECMO, recent case reports indicate that provided heparin therapy is controlled, surgery need not preclude E010 , Bartlett et al. 1974 .
Active bleeding in a patient proposed for ECl\10 poses another problem. Experience has shown that the presence of disseminated intravascular coagulation (DIC) need not preclude EC\10, and in fact the removal of hypoxia, acidosis and the use of heparin may reverse it (Hill et al. 1974 , Bartlett et al. 1974 ). If the stimulus to DIC persists (e.g. sepsis) then the success of ECMO may be prejudiced (Hill et al. 1974 ).
OXYGENATORS FOR EXTRACtmpOREAL OXYGE);ATION OF THE BLOOD
There seems little doubt that for extracorporeal oxygenation lasting longer than 4-6 hours, a bubble oxygenator, despite its considerable gas exchanging efficiency, causes significant trauma to blood components~ namely cells and proteins (Lee et al. ] 96], Dearing, Simpson and Yasko ] 969, Lee et al. 1971, Galletti 1(71) . In this context the blood-gas interface is important though there are those who dispute these limitations of bubble oxygenators (Kayser et al. 1974 ). The use of semi-permeable membranes interposed between the blood and gas phases in oxygenators was pioneered in the 1950's and since then gradual improvement in design characteristics has allowed production of compact membrane ()xygenators. These cause minimal blood component trauma and provide efficient gas exchange, though not of the same order as bubble oxygenators. At present the most commonly used (Gille and Bagniewski 1976) commercially available membrane lungs for prolongeel EC1\10 are the Lande-Edwards membrane lung of flat sheet construction (Rea ct al. 1973, Bartlett ct al. 1(74) and the KolobO\v spiral coil lung (Sci-med) (Zapol ct al. 1975) . The third type of membrane available is the newer Teflo microporous membrane lung (Travenol).
The lifetime of this lung does not appear to be long enough for prolonged EC\IO (Karlson et al. 1974 ) (the manufacturers recommended life time is twelve hours). The B:am.,on m2mbrane lung has been USed for a large number of Anaesthesia and Intensive Care, Jfay, 1977 perfusions for acute respiratory failure (Heiden et al. 1975) . It is, however, a unique system used in only one centre, and is not commercially available. The choice of membrane depends on many local factors, but it appears that the Kolobow spiral coil may be most efficient with regard to gas transfer, and cause acceptable degrees of haemolysis , Bartlett et al. 1974 , Ionescu and Wooler 1976 . The membrane in the spiral coil lung is resistant to rupture by high arterial line pressures, and blood can be safely pumped through it. Passage of the blood through the Lande-Edwards should be by gravity drainage (manufacturers recommendation) and this has been associated with deteriorating function over long periods (Bartlett et al. 1974) , though the Lande-Edwards membrane has been used successfully with blood pumped through it (Bartlett et al. 1974) .
The priming technique required to remove the sodium chloride from the Lande-Edwards membranes is complex and time consuming.
The surface area of membrane needed for ECMO is determined largely by the type of oxygenator selected. Other considerations are the oxygen consumption of the patient (presence of sepsis) and the contribution to total gas exchange that is expected of the oxygenator. The importance of not underestimating the surface area of membrane oxygenator required has been stressed (Zapol et al. 1972 ). There are those who consider the oxygenator should be capable of total cardiopulmonary bypass, even in the face of the very high requirements seen in some patients in respiratory failure (Bartlett et al. 1974) .
Between a half to one square metre membrane surface area per 10 kg body weight would seem an appropriate range for the Kolobow spiral coil lung, though for the Lande-Edwards oxygenator, in excess of one square metre per 10 kg body weight is needed (Gille and Bagniewski 1976) . These membrane areas have on occasion been far exceeded (Bartlett et al. 1974 ). Carbon dioxide elimination during ECMO is rarely a problem and can be controlled by both the composition and rate of fresh gas flow through the membrane, and by mechanical ventilation of the lungs (Lefrak et al. 1973 , Bartlett et al. 1974 .
Both Lande-Edwards and the Kolobow spiral coil membrane provide good gas transfer for prolonged periods , Bartlett et al. 1974 . They do, however, sometimes need changing, and an outflow oxygenation saturation of less than 90% has been used as one indication Anaesthesia and Intensive Care, Vol. V, No. 2, May, 1977 . The pressure gradient developed across the membrane can also be used as an indication of the need to change the oxygenator. A disadvantage of changing the oxygenator during ECMO may be increased platelet consumption and protein loss with exposure of the blood to new membrane surfaces.
CANNULATION FOR ECMO
The most appropriate mode of cannulation for partial ECMO is as yet undetermined. Important factors to consider in such a choice are:
1. Provision of adequate venous return to the oxygenator. 2. Return to the body of oxygenated blood in such a way that the blood supplying vital organs, the brain and heart particularly, is well oxygenated. 3. Provision of the best environment for the healing of damaged lung tissue. 4. Minimization of risks of emboli arising endogenously, or exogenously from within ECMO apparatus.
The basic varieties of cannulation are: 1. Veno-venous: Blood is withdrawn from a major vein and after oxygenation returned to another major vein. 2. Venoarterial: Blood is withdrawn from a major vein and subsequently returned to a major artery.
Mixed venovenous and venoarterial per fusion:
Blood is withdrawn from a major vein and returned to both a major artery and a major vein. Before considering the various methods, a brief discussion of cannulae and their insertion is warranted. The cannulae should be of maximum possible internal diameter (to reduce resistance) and be non-collapsible and unkinkable. A segmented reinforced polyurethane cannula has been widely used in clinical perfusion.
A verage dimensions for a venous drainage cannula inserted into the femoral vein of an adult would be 9·5 mm internal diameter, 10 ·85 mm outside diameter . Femoral arterial cannulae 6·5-8·12 mm O.D. , McEnany et al. 1975 . The length of the cannula depends on the proposed level of situation of the tip (vide infra), and the site of insertion. The former can be located radiologically.
Surgery for cannula insertion must be meticulous with regard to haemostasis. Electrocautery of all exposed subcutaneous surfaces is mandatory. The technique of arterial cannulation is debatable. Arterial transection for cannulation with subsequent reapproximation of the severed ends may be associated with a high incidence of false aneurysm or arterial rupture . Better alternatives for repair of arterial transection are the use of dacron or vein grafts. A longitudinal arteriotomy can be used for cannula insertion and the later repair performed with an autologous vein patch (:\lcEnany et al. 1975) . Distal cannulation of arteries to maintain viability of extremities and of veins to prevent troublesome oedema should be performed.
VEi\O-VEi\OUS CANNULATIOX
This is the oldest method used for prolonged EC1\10 and is the simplest, avoiding the difficulties and dangers of cannulating a major artery. It has been used successfully only very recently (Kolobow et al. 1975) . Venous drainage by gravity from the inferior vena cava via the common femoral vein is satisfactory. The blood is then pumped into the superior vena cava via the internal jugular vein. Provided the lower venous cannula is below the level of the diaphragm, there should be no recirculation between the cannulae, even at high flow rates (Kanarek et al. 1974) . Distal cannulation of the cannulated veins is advisable .
The outstanding advantage of V-V perfusion is that the distribution of the oxygenated blood returned to the body is physiological by means of the left ventricle. Both the coronary and cerebral circulations benefit from the increased mixed venous oxygenation. As the terminal bronchioles and alveoli are nourished bv both the pulmonary and bronchial arteries, tIle high oxygen content of the pulmonary artery blood seen with V-V perfusion should improve the environment for pulmonary parenchymal healing (:\IcEnany et al. 1975) .
One of the disadvantages of V-V perfusion, however, may be haemodynamic. In respiratory failure, the pulmonary artery pressure and the pulmonary wedge pressure may be high (Geelhoed et al. 1975 ) and venovenous perfusion does not reduce pulmonary artery pressure or blood flow , Geelhoed et al. 1975 , Hill et al. 1974 ). This high pulmonary artery pressure may contribute to impaired pulmonary function by increasing fluid transudation into the interstitium , Bartlett et al. 1974 , Geelhoed et al. 1975 . During venovenous perfusion, pulmonary function as measured by effective compliance (Geelhoed et al. 1975 ) and ventilator characteristics has not shown improvement. However, the need to reduce pulmonary pressure and blood flow has not been proven, though it may provide more favourable conditions for pulmonary parenchymal function and healing. Failure of either the right or the left ventricles is not helped by V-V perfusion, as load on these compartments is not reduced. Alleviation of hypoxic myocardial depression may occur. The maximal bypass flow obtainable with veno-venous bypass is less than that with veno-arterial (Geelhoed et al. 1975 ). This is a disadvantage when very high flows are needed for short periods off the ventilator (for intensive pulmonary toilet). The passage of all mechanically oxygenated blood through the lungs means that the pulmonary parenchyma filters any particulate or gaseous emboli. This may increase pulmonary parenchymal damage, but does protect vital organs from embolic damage of exogenous origin. Also the possibility of emboli arising from the pulmonary veins is reduced by the high flow of blood through the lungs (z'ide infra). At present most centres are not using pure veno-venous perfusion. It may, however, be the method of choice for small children ) and for neonates (White et al. 1971 ).
VE~w-ARTERIAL PERFUSION
Here venous return is provided by cannulation of the femoral vein, and (or) the internal jugular vein, and withdrawal of blood from the vena cava near the right atrium. Oxygenated blood is returned to a major artery. Cannulation of a major artery is not without risk-dissection and embolization, associated with retrograde flow in a patient with athero-sclerotic vessels, do occur.
Veno arterial perfusion does decompress the pulmonary circulation with reduction of pulmonary artery pressure and flow , Geelhoed et al. 1975 , Bartlett et al. 1974 . As already mentioned this may reduce interstitial pulmonary water (Geelhoed et al. 1975 , Bartlett et al. 1974 . It may also improve the ratio of ventilation to perfusion in the diseased lung, and enable the lung to better oxygenate blood flowing through it (Geelhoed et al. 1975, Hanson Anaesthesia and Intensive Care, Vol. V, Xo. 2, '1fay. 1977 Xo. 2, '1fay. et al. 1974 . The work of the right ventricle is also reduced.
Oxygenated blood returned to a major artery may not be distributed appropriately. If the femoral artery is used and the cannula threaded into the abdominal aorta, at low flows this oxygenated blood is distributed only to the lower half of the body (Geelhoed et al. 1975 , Kanarek et al. 1974 . Some, however, have found that in this situation the oxygen tension of blood taken from the radial arteries is increased (Geelhoed et al. 1975 , Hanson et al. 1974 .
As this is not blood oxygenated by the membrane (unless the bypass flow is greater than 85% of the cardiac output), other explanations must be sought. It may be due to an increase in mixed venous oxygen content, but perhaps more likely to improved pulmonary function during V-A perfusion (Geelhoed et al. 1975 , Hanson et al. 1974 .
Despite some improvement of oxygenation of the upper body with femoral artery (abdominal aortic) cannulation, it is preferable to return the oxygenated blood in such a way that it is distributed to the coronary and cerebral circulations, even at low bypass flow rates i.e. less than 50% of the patients cardiac output. One possible alternative is cannulation of the brachial or axillary arteries and the introduction of the blood into the brachiocephalic artery (Rea et al. 1973 , Bartlett et al. 1974 ). This provides adequate distribution (Kanarek et al. 1974 ). If the axillary artery is cannulated high enough, collateral circulation is such that distal cannulation of the axillary artery is unnecessary (Bartlett et al. 1974) . Despite these advantages, the artery is small. The use of a small bore cannula results in a high arterial line pressure with an increased risk of accidental decannulation, and damage to the arterial wall. Also the risks of infection and extensive electrocoagulation in the region of the brachial plexus are significant.
Another alternative is to return the oxygenated blood into the aortic arch through a cannula introduced through the common femoral artery. The cannula tip may be located just distal to the left subclavian artery. Radionucleotide imaging shows that this cannulation provides good flow from the cannula to the left carotid artery, but not to the right carotid , Kanarek et al. 1974 . The coronary arteries are still supplied by blood oxygenated in the lungs. This mode of cannulation has been used clinically (Zapol et al. 1975, Cooper Anaesthesia and Intensive Care, Vol. V, No. 2, May, 1977 ). More recently, cannulation of the ascending aorta has been performed (McEnany et al. 1975) . The cannula tip is placed just distal to the aortic valve and provides a good flow of oxygenated blood to both the coronary and cerebral circulations (McEnany et al. 1975 ). There has been no evidence of trauma to the aortic valve or aortic incompetence with prolonged flow at 3-6 litres per minute. Also no left ventricular failure or rise in left atrial pressure (as measured by the pulmonary wedge pressure) has occurred.
There is a possibility that V-A perfusion is associated with emboli to the heart, brain and more peripheral circulation, and that these emboli arise from the pulmonary veins (Ratliff et al. 1975) . It is postulated that the reduction of pulmonary artery pressure and flow associated with V-A perfusion encourages ischaemic necrosis and sloughing of lung tissue, and thrombosis within the pulmonary venous circulation (Ratliff et al. 1975) . To overcome these possible deleterious effects of excessive pulmonary decompression, mixed veno-venous and veno-arterial cannulation has been devised. Blood is drained from the inferior vena cava at the level of the diaphragm (via the femoral vein), oxygenated, and returned to both the femoral artery and to the superior vena cava or the right ventricle (Hill et al. 1974) . This system provides the pulmonary circulation with oxygenated blood at a rate that can be controlled by means of a flow-meter. The pulmonary artery pressure can be reduced as desired, with the accompanying possible advantages of improved lung function.
A pulmonary artery oxygen saturation of 70(0 and a pressure of 20 mm Hg is suggested (HIll et al. 1974) . Veno-venous perfusion coupled with veno-arterial allows physiological distribution by the left ventricle of oxygenated blood to the cerebral and coronary circulations. There should be no shunting of blood between the superior vena cava cannula and that in the inferior vena cava provided the latter is below the diaphragm (Kanarek et al. 1974 ). With this system the lungs filter any emboli that may damage the cerebral or coronary circulations. There is however, the need for an extra incision and the consequent increased risk of bleeding with this cannulation method as compared to femoro-femoral cannulation.
To date, there is no definite evidence as to which cannulation method is the best, though increased numbers of patients treated may provide an answer. Numerically, the great majority of perfusions have been venoarterial, with only relatively few patients undergoing veno-venous or mixed veno-venous and venoarterial bypass (Gille and Bagniewski 1976) .
BYPASS CIRCUITS
Details of extracorporeal circuits are matters of individual preference and experience, and are determined to some extent by the type of oxygenator used, and whether it is placed on the arterial or venous side of the pump. In general terms, however, the following should be considered :
l. Circuit priming volume: This should be kept as small as possible with regard to both volume (1,000 ml in eluding oxygenator) and surface area (vide infra). Blood reservoirs should be as small as possible or can be omitted (Bartlett et al. 1974 ). This necessitates a control of pump speed which is determined automatically by the venous return. Other automatic devices which give added safety to bypass undertaken for prolonged periods have been described (Duffin, Martin and Cooper 1976) . Heat loss from the bypass circuit may be considerable and is increased by evaporative water loss from the membrane oxygenator. This can be overcome with a heat exchanger (Bartlett et al. 1974 ) though the increased priming volume and surface area this involves can be avoided by the use of a canopy enveloping the bypass circuit and use of infrared lighting . Any areas of blood stagnation within the circuit accessories or reservoirs should be minimized to avoid micro-emboli formation.
2. The pump: Although roller pumps, if properly adjusted do not cause undue blood trauma, a bypass circuit with only one pump present is probably to be preferred. A roller pump is satisfactory, as the unresolved question of possible deleterious effects of continuous flow are avoided by maintenance of pulsatile flow by left ventricular ejection (Sanderson, Wright and Sims 1972, Boucher et al. 1974) . This is so as long as bypass flow rate is less than 80-90% of cardiac output, at which point the systemic arterial pulse pressure begins to decrease (Bartlett et al. 1974) . The pump rollers should be set non-ocelusively (Heiden et al. 1975 , Hill ct al. 1974 . As this makes the pump "load-sensitive" (i.e. the stroke volume is dependent upon outflow pressure) it necessitates the use of a flow meter in the arterial line (Zapol ct al. 1975) or of prepared graphs (constructed for a given degree of roller ocelusiveness) which relate pump output to various arterial line pressures.
3. Pump tubing: There have been recent suggestions that silicone surfaces free of silica fillers may result in improved platelet function and less destruction during cardiopulmonary bypass (Kolobow et al. 1974) .
PRIMING FOR EC\10
Since haemodilution during cardiopulmonary bypass was advocated (Zuhdi, Carey and Cutter 1963) , the concept of diluting patients' blood with extracorporeal circuit priming solution has become widespread. The advantages of haemodilution inelude conservation of blood; improved patient safety by reducing the use of multiple units of cross-matched blood; and diminution of the products of trauma to formed elements in the blood by reducing the concentration of plasma proteins and blood cells present. Tissue perfusion may also be improved by haemodilution. These advantages would apply to ECMO but as oxygen tensions during ECMO may be low, near normal haematocrit levels are desirable to ensure adequate oxygen carriage to the tissues. Probably the haematocrit should be maintained with 5-10% of normal valves . Haemodilution also results in reduction of plasma protein concentrations, and concomitantly reduction of the colloid osmotic pressure of the blood. This results in movement of fluid from the intravascular to the interstitial space (Wcbber and Garnett 1973, Beattie et al. 1972 ). In short term cardiopulmonary bypass for cardiac surgery, the reduction of plasma protein levels caused hy haemodilution is followed by an incomplete compensatory rise in the plasma protein levels. This is due to an influx of albumin into the intravascular space (Beattie et al. 1974) . The amount of albumin available for exchange in this way is about 40 g (Beeken et al. 1962) . Despite this compensation, the reduction of colloid osmotic pressure is such that loss of fluid into the extravascular compartment occurs (Beattie et al. 1974 , :'IIarty et al. 1973 . In the context of prolonged extracorporeal oxygenation it can be postulated that excessive initial haemodilution, coupled with blood protein loss onto oxygenator membranes, and subsequent use of non-protein containing solutions, would exceed the body's ability to compensate for the reduction in osmotic pressure. This would result in continual extravasation of fluid into the interstitial spaces causing oedemaparticularly disadvantageous In the lungs. This occurs in laboratory animals undergoing prolonged perfusion. Hormonal mechanisms for fluid retention may also operate (Brinsfield et al. 1964) . Two approaches to maintenance of red cell and plasma protein levels are available. Firstly, by using an extracorporeal circuit of as small a volume as possible any dilution of the patient's blood by the prime is minimized. Secondly, the prime must be provided with adequate protein and red cell content of its own. Some membrane types cause adherence of protein to the membrane surface and an initial priming of the circuit with an albumin containing solution is an advantage (Bartlett et al. 1974, Lande-Edwards and Bloch 1970) . A whole blood prime or a combination of blood and crystalloid solution with added protein (75 grams per litre of crystalloid) may then be used (Bartlett et al. 1974 , Hanson et al. 1974 . Fresh blood is preferable and the pH of the prime should be carefully adjusted to physiological levels. The use of synthetic colloid solutions to maintain colloid osmotic pressure is of uncertain value. Although suitable in the context of short term bypass, the plasma half life of synthetic colloids is relatively short and they are then lost to the intravascular space.
The haematocrit of the patient should be monitored regularly during bypass. In fact, with a membrane lung and a properly adjusted pump, the loss of red cells besides that due to sampling or bleeding, should be minimal. Following the colloid osmotic pressure is more difficult as neither the haematocrit nor the plasma osmolality bear a reliable relationship to it (Beattie et al. 1974) . Regular measure of plasma total protein level would seem to be the best method (Beattie et al. 1974) , and albumin infusion should be used to maintain normal levels.
FLUID BALANCE DURING ECMO
To date details of fluid balance management during human long term bypass have been scanty. Animal experiments have shown that meticulous control of fluid balance and plasma colloid osmotic pressure are essential during long term bypass. There is a tendency for fluid to pass from the intravascular to the interstitial space, with formation of interstitial oedema. To help minimize passage of fluid into the tissues, fluid intake must be exactly controlled and not be allowed to exceed fluicl losses as measured or estimated (Hanson et al. 1974) . A weighing bed is useful for following the accuracy of estimates. Sources of fluid loss Anaesthesia and Intensive Care, Vol. V, No. 2, Jl.lay, 1!177 B to consider are respiratory and other insensible loss (partiCUlarly in presence of pyrexia), and loss from the membrane due to evaporation (Bartlett et al. 1974) . Also bleeding and blood sampling must be considered. The nature of administered fluid will be determined both by the nature of losses and by measurement of biochemical parameters. Flushing of monitoring lines becomes a significant source of fluid intake over a period of days. If noncolloid intake exceeds urine output, diuretics should be used to restore the balance (Peirce et al. 1971) .
In healthy animals renal function is unchanged by prolonged ECMO. Renal impairment in patients with acute respiratory failure may be improved by increased renal perfusion pressure and relief of hypoxia associated with the institution of ECMO. If failure develops or persists, haemodialysis can readily be performed by removing blood from the ECMO circ'lit (Bartlett et al. 1974 , Hanson et al. 1974 . Dialysis should begin before severe renal insufficiency develops, as marked fluid shifts associated with it can be troublesome during bypass. Peritoneal dialysis has been used successfully during ECMO (Bartlett et al. 1974) but it would appear to be associated with risk of intraperitoneal haemorrhage or infection. Prognosis during ECMO is not considered to be adversely affected by dialysis (Hill et al. 1974) .
It should be noted that oliguria reduces heparin requirements (Hill et al. 1974 ).
BLOOD AND PROLONGED ECMO
Haemorrhage during prolonged extracorporeal circulation and oxygenation is a major problem (Hanson et al. 1974, Gille and Bagniewski 1976) and has on many occasions either been the cause of premature cessation of EC\IO or been directly related to the death of the patient. Such bleeding may be overt from surgical incisions or be internal. Contributing factors may be 1. Heparin therapy 2. Platelet changes: since adequate heparinization reduces coagulability of the blood, platelet haemostatic activity is vital in the prevention of bleeding. This can be impaired by reduction in platelet function or number.
Changes in clotting jUllction
The effect of EC1\10 on blood has been studied in animals and in man. In sheep, during prolonged EC1\10 there is an impairment of platelet function as measured by platelet aggregation induced with ADP, collagen and adrenaline (Fong et al. 1974) . Suggested mechanisms for reduction of platelet function include (Tamari et al. 1975) :
(a) release of ADP by red cell haemolysis causing excessive platelet aggregation and de aggregation which temporarily renders the platelets refractory. (b) preferential destruction of the youngest and most active platelets. (c) reversible adherence to foreign surfaces, then release into the circulation with activity impaired. Platelet numbers are also reduced in animals during prolonged ECMO, the reduction occurring at the initiation of bypass and persisting throughout bypass (Fong et al. 1974 , de Leval et al. 1975 . Human in vitro studies reveal similar changes in platelet number and function (Tamari et al. 1975) , and during clinical ECMO the platelet count falls at commencement of bypass, with some recovery at its termination (Heiden et al. 197.5, Bloom et al. 1974 , Bartlett et al. 1974 . Suggested mechanisms for reduction in platelet counts include:
(a) Loss into the extracorporeal circuit with deposition on tubing and membrane (de Leval et al. ] 972, Salzman 1963). (b) Extracorporeal lllJury followed by destruction or storage in the reticulo endothelial system or lungs (Heiden et al. 1975 , Ashmore, Svitek and Ambrose ]91i8). In dogs at least it appears that microaggregates of platelets form after exposure to foreign surfaces, are taken up by the reticuloendothelial cells in the liver, and later released at the cessation of bypass (de Leval et al. 1975 . (c) Decreased bone marrow production (Heiden et al. 1975) . \Vhatever the reason, at present thrombocytopenia during prolonged EOIO must be accepted, though opinion as to lower permissible levels varies. Platelet transfusion is generally recommended if the count falls below 20-30 thousand , Bartlett et al. 1974 . It provides only transient relief of thrombocytopenia (Hill et al. ] 972) and may , Bartlett et al. 1974 or may not (Heiden et al. 1975) be helpful in treatment of active bleeding.
AI.though membrane oxygenators produce less parbculate and gas microemboli than do bubble oxygenators (Solis et al. 1975 , Dutton et al. 1974 , and although membrane oxygenators act as a filter of pore size 100-200 mm, smaller platelet aggregates and other micro-emboli may deposit in vital organs and impair their function (Carlson et al. 1973) . Microfilters will remove these microemboli, but they have several disadvantages that may be of importance during long term bypass. They cause haemolysis, remove platelets from the blood and increase resistance to blood fiow (Buley and Lumley 1975, Dunbar, Price and Cannarella 1974) . They are used by some during ECMO (Rea et al. 1973) but are omitted by others with no resultant overt evidence of embolic phenomena , Bartlett et al. 1974 . It may be that endogenous emboli are of more importance (Heiden et al. 1975) . If a microfilter is used it should be changed at regular intervals (Gervin et al. 1974) . Microemboli formation is reduced by elimination of blood stagnation and of areas exposed to excessive heat (e.g. photoelectric cells in blood reservoir level control). All cellular solutions (apart from platelets) should undergo ultrafiltration before administration to the patient.
Oxygenators with a blood gas interface are associated with protein denaturation and destruction of coagUlation factors-particularly factors Y, YIIl and IX. :\Iembrane oxygenators cause less disturbance in this respect (Lee et al. 1961 , Dobell et al. 1965 . In sheep, after a drop in fibrinogen, factor Y and factor YIIl levels on initiation of bypass, values soon return to normal, and a rebound increase in these factors to 2-3 times baselines valves occurs after cessation of bypass (Bartlett et al. 1974 , Fong et al. 1974 . Results in man during prolonged EG\IO show similar minimal interference with clotting parameters (Heiden et al. 1975 , Bartlett et al. 1974 , Fong et al. 1974 . In treatment of acute respiratory failure by EOIO, before institution of bypass an abnormal coagulation state is often present with some degree of consumption coagulopathy with thrombocytopenia. Low clotting factor levels and increased fibrinogen degradation products. These changes are often reversed by ECl\IO due either to heparinization, alleviation of hypoxia or improved tissue perfusion associated with bypass (Hill et al. 1974 , Bartlett et al. 1974 .
Red cell damage with a membrane oxygenator system should be minimal as evidenced by haemolysis or altered red cell morphology, although red cell survival time is reduced (Galletti 1971 , Awad et al. 1974 , Vervloet, Edwards and Edwards 1970 . Average plasma haemoglobin levels should be below 25 mg per cent , Hanson et al. 1974 , Zapol et al. 1972 . After initiation of ECMO additional red cells should only be needed to replace loss due to sampling or haemorrhage. White blood cells show a reduction in number at the onset of bypass. Within several hours, however, the trend is reversed and a leucocytosis occurs with immature forms invading the circulation. Simultaneously the bone marrow shows myeloid stimulation (Galletti 1971 . The relationship of these changes to phagocytosis and the resistance to infection is uncertain.
CONTROL OF HEPARIN THERAPY DURING ECMO
Until non thrombogenic surfaces are available for routine use, heparin therapy during cardiopulmonary bypass is essential. The control of the level of heparinization is of vital importance. Inadequate levels are associated with derangement of blood parameters due to blood aggregates occurring on the membrane oxygenator (Awad, Matte and Brassard 1973) . Of course overt clots and emboli can also develop. Excessive heparinization will result in haemorrhage. Heparin levels needed may be influenced by the platelet count (Marcus 1969, Zapol and Kitz 1972) . Monitoring of heparin therapy can be achieved in several ways, including whole blood cle>tting time, partial thromboplastin time and activated coagUlation time. There appears to be good correlation between Lee-White whole blood clotting time and the activated coagulation time (Hattersley 1966) . The use of the activated coagulation time is rapid, gives a definite end point even with high levels of heparinization, and can be performed as often as desired at the bed-side. Lee-White clotting times of 35-45 minutes are commonly used during ECMO (Hanson et al. 1974 ) though some use a clotting time as low as 20 minutes .
Corresponding activated coagulation times are 180-300 seconds and bovine heparin at 15-45 units/hr/kg is needed to maintain this level after initial heparinization (Bartlett et al. 1975 , Hanson et al. 1974 . When these levels of heparinization are used prolonged low flows through the oxygenator should be avoided . Heparin requirements may vary with the patient's urine output .
BIOCHEMISTRY AND PROLONGED ECMO Serum electrolytes, serum enzymes and liver function tests during prolonged uncomplicated ECMO have remained unremarkable (Bartlett et al. 1974, Kolobow, Zapol and Sigman 1970) .
Sepsis and Prolonged ECMO
Primary lung sepsis causing acute respiratory insufficiency and treated by ECMO perhaps holds a poorer prognosis than pulmonary insufficiency related to pulmonary capillary or alveolar injury without infection (Bartlett et al. 1974) .
Even if no sepsis is present, the development of infection during prolonged ECMO is very common and a significant cause of mortality (Gille and Bagniewski 1976) . This particularly applies to gram negative organisms (Bartlett et al. 1974) . Several factors may contribute to the high incidence of bacteraemia during prolonged bypass (Bartlett et al. 1974) . Firstly, there are multiple intravascular catheters for bypass and monitoring. Secondly, other multiple access sites to the circulation are present (tracheostomy, chest drains, urinary catheter). Thirdly, there is possible suppression of phagocytosis, and reduction of the bacteriocidal activity of the reticulo endothelial system (Subramanian et al. 1968, Silva, Hoeksema and Fekety 1973) . Finally, there may be some protein denaturation with loss of immunocompetence of gamma globulin and complement (Lee and Hairston 1971) . Obviously strict asceptic measures are essential. The use of prophylactic antibiotics is controversial. Frequent culture of cannulation sites, tracheostomy, and urine and blood are necessary. The other aspect of sepsis that deserves mention is its effect on the cardiovascular system. It may be associated with a high cardiac output and a hypermetabolic state. The increase in myocardial and peripheral oxygen demand may usefully be reduced by some degree of hypothermia-readily achieved by ECMO. Sepsis may also precipitate, or be a continuing source of stimulation for disseminated intravascular coagulation, which if not controlled while on bypass may cause fatal haemorrhage (Hill et d. 1974 ).
Nutrition and Prolonged ECMO
Specific statement by those experienced in long term bypass is scarce, but there seems no reason for any difference of broad approach from that used in other intensive care situations. Gastric tube feeding or intravenous alimentation to provide five calories for every ml of oxygen consumed have been recommended (Bartlett et al. 1974) . Rapid infusion of various calorie rich solutions may create troublesome fluid shifts. Absorption from the gut during EC\IO may be uncertain as gastric and intestinal secretion and absorption may not be normal. This complicates fluid balance calculations and intravenous alimentation may be preferable.
BYPASS FLOW RATES AXD DrSCOXTIXl'ATION OF BYPASS
The bypass flow rate should be such that the contribution of the membrane oxygenator to the oxygenation of the blood allows the inspired oxygen concentration to be reduced (less than 60%) and the inflation and end expiratory pressures to be minimized. In a series of recent perfusions, the average bypass flow used was of the order of 0 ·5litresj10 kg body weight/minute. At times when pulmonary therapy necessitates removal of the patient from the ventilator, the bypass flow will need to be high . If pulmonary function improves on EC\IO then gradual weaning from the oxygenator can be performed. Criteria for cessation of bypa,;s as suggested in the American National Heart and Lung Institute protocol for the random study on EC\IO, are a Pa0 2 of consistently greater than 70 mm Hg in three samples each taken two hour,.; apart under the following conditions: Fi0 2 = ()·6; PEEP,=;j cm H 2 0 and EC\lO fiow= (). 3 litres/minute. Cessation of b~'pass is indicated if major irreversible central nern)liS system d"sfunction develops or if severe cardiac fa'ilure and refractory shock occur. A more difficult problem °is posed by the patient. who remains well while on EC\IO, but shows no 1I11pron'ment, or deterioration, in lung function after som(' days of treatment. Inahility to achil'\T the bl(;nd gas results mentioned above \\"ithin fin' days on EC\IO is used in the Kationall-Ieart and Lung Institute study as an indication to di,,continue it. This is supported b~' the fact that tho"e who sur\'i\'e \\·ith the use of EC\IO undergo short perfusions (CiJle and Bagnil'\\'"ki 1 !17H).
Other n1l'ano-; han~ been usecl to indicate thl' presence of SeYl'IT, irn'\Trsihll' pulmonan' de"truction. Dartldt d al. (l!1j.J) "uggest reducing h\pas.,; 110\\' graduall\·. This (lirects the \"('nmb return to tIll' right \"entri.-Je. .\ rapid rise in pulJ1lonan' aden' preS5Url' and a fall in sy~tl'lllic blood pn'ssufe suggesh blood flow lim'itatiun in the I\lng,,; by a lligh fixed pulmonan' \'ascular resistance (rdkcting pulmonary fibrosis and parenchymal destruction). If a rapidly acting vasodilator is then injected directly into the pulmonary artery, and there is no lowering of pulmonary vascular resistance, hypoxia hypercarbia and acidosis are eliminated as causes of this high resistance. A higher dose of vasodilator will have an effect ')n the systemic vascular resistance, but still none of the pulmonary vascular resistance (Bartlett et al. 1974) . A pulmonary angiogram may reveal very poor pulmonary blood flow, again indicating severe irreversible pulmonary parenchymal destruction.
